Angiodynamics (ANGO) Equity Ratio (2011 - 2026)

Angiodynamics has reported Equity Ratio for 16 years, with the latest figure at 0.67 in Q1 2026.

• For the quarter ending Q1 2026, Equity Ratio rose 2.12% year-over-year to 0.67; the trailing twelve-month figure through Feb 2026 stood at 0.67 (up 2.12% YoY), and the FY2025 full-year result was 0.65, up 0.92% from the prior year.
• Equity Ratio for Q1 2026 stood at 0.67, up from 0.65 in the prior quarter.
• The five-year high for Equity Ratio was 0.87 in Q3 2023, with the low at 0.64 in Q4 2024.
• Historically, Equity Ratio has averaged 0.71 across 5 years, with a median of 0.67 in 2025.
• Annual changes were most pronounced in 2023 — Equity Ratio advanced 16.65% — and 2024, when it fell 22.7%.
• Angiodynamics' Equity Ratio stood at 0.73 in 2022, then advanced by 9.88% to 0.8 in 2023, then retreated by 20.23% to 0.64 in 2024, then gained by 2.07% to 0.65 in 2025, then climbed by 1.71% to 0.67 in 2026.
• The last three Equity Ratio figures came in at 0.67 (Q1 2026), 0.65 (Q4 2025), and 0.67 (Q3 2025), per Business Quant data.